Company Analysis

HCA Healthcare, Inc. (HCA)

NYSE: HCA · Services-General Medical & Surgical Hospitals, NEC · Nashville, TN · filing with the SEC since 1994
Grade6.3
◀ Past 7.5● Present 6.6▶ Future 4.5
The companyfiscal 2025, as filed
Revenue$75.60B+7.1%
Net income$6.78B+17.8%
Earnings per share$28.33+28.8%
Operating cash flow$12.64B+20.2%
Cash$1.04B-46.2%
Debt$44.28B+2.9%
Shareholders’ equity-$2.77B-599.3%
Shares, diluted239.5M-8.5%
Return on equityn/a
The recordfrom its filings
Filings in 202684
Newest filingNov 10 · 144
Annual reportFeb 10, 2026
Quarterly reportOct 29, 2026
Next report due10-K by Mar 1
Insider sales, 12 months$47.5M
Insider buys, 12 months$0.00
Patents granted140
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $78.70BNet income $6.78BCash from operations $11.17Bthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

The company now

HCA Healthcare reported third-quarter 2026 revenue of $19.849 billion on 27 October, up 3.6 percent from a year earlier 1. Net income attributable to the company fell 3.9 percent to $1.579 billion 1. Diluted earnings per share came to $7.27, a 4.5 percent increase 1.

A shift toward patients with no insurance was the main drag 1. The company estimated that the shift cut income before income taxes by about $400 million in the quarter, mostly from patients who lost coverage on the health insurance exchanges 1. Same facility uninsured admissions rose 27.4 percent 2.

The 10-Q ties the rise to the expiration of the enhanced premium tax credits at the end of 2025, which had helped people buy plans on those exchanges 2. The company also says approvals of Medicaid supplemental payment programs, mainly in Florida, helped revenue 2.

The company now believes its full year 2026 results will land in the upper half of the guidance ranges it issued on 14 July 1. Those ranges are revenue of $77.0 billion to $79.5 billion and net income attributable to the company of $6.3 billion to $6.7 billion 1.

On 2 November a subsidiary, HCA Inc., proposed a public offering of senior notes and said it would redeem all $1.200 billion of its 4.500% senior notes due February 2027 on 2 December 5. The redemption depends on the offering's proceeds arriving first, and the release says the money may also repay commercial paper and credit facility borrowings 54.

As of Nov 4, 2026. Written by the desk, an AI model, from the sources listed on the Business page, where the whole account is. Nothing here is advice.

Newer filings are on file since this was written; an update is queued.

News

Nov 10, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 5, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton HCA · research, not advice